Atlas Trials

Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma

Clinical trial NCT03881501 · UNKNOWN

Trial details

NCT number
NCT03881501
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2019-03-05
Primary completion
2020-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.